BioCryst Pharmaceuticals Inc. (BCRX)

2.38
NASDAQ : Health Technology
Prev Close 2.40
Day Low/High 2.35 / 2.44
52 Wk Low/High 2.32 / 9.95
Avg Volume 1.45M
Exchange NASDAQ
Shares Outstanding 110.44M
Market Cap 263.39M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)
Trade-Ideas: Biocryst Pharmaceuticals (BCRX) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: Biocryst Pharmaceuticals (BCRX) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a "dead cat bounce" (down big yesterday but up big today) candidate

BioCryst Pharmaceuticals (BCRX) Stock Drops Despite Positive Drug Trial Results

BioCryst Pharmaceuticals (BCRX) Stock Drops Despite Positive Drug Trial Results

BioCryst Pharmaceuticals (BCRX) shares are down over 15% in afternoon trading despite positive phase 1 test results after the company said that some patients experienced adverse reactions.

Biocryst Pharmaceuticals (BCRX) Stock: Weak On High Volume Today

Biocryst Pharmaceuticals (BCRX) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a weak on high relative volume candidate

Trade-Ideas: Biocryst Pharmaceuticals (BCRX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Biocryst Pharmaceuticals (BCRX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a strong on high relative volume candidate

3 Stocks Pushing The Health Care Sector Lower

3 Stocks Pushing The Health Care Sector Lower

TheStreet highlights 3 stocks pushing the Health Care sector lower today.

Market News: American Express, BioCryst Pharmaceuticals, CF Industries

Market News: American Express, BioCryst Pharmaceuticals, CF Industries

The stock markets in the United States ended the trading down as investors resumed selling their stockholdings in biotechnology and commodity companies. Sign up for our free newsletter Yesterday, the...

BioCryst Pharmaceuticals Becomes Oversold (BCRX)

BioCryst Pharmaceuticals Becomes Oversold (BCRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of March 2016 Options Trading For BioCryst Pharmaceuticals (BCRX)

First Week of March 2016 Options Trading For BioCryst Pharmaceuticals (BCRX)

Investors in BioCryst Pharmaceuticals, Inc. saw new options become available this week, for the March 2016 expiration.

BioCryst Pharmaceuticals Stock Sees Short Interest Move 20% Lower

BioCryst Pharmaceuticals Stock Sees Short Interest Move 20% Lower

The most recent short interest data has been released by the NASDAQ for the 06/30/2015 settlement date, which shows a 2,400,172 share decrease in total short interest for BioCryst Pharmaceuticals, Inc. , to 9,652,920, a decrease of 19.91% since 06/15/2015.

Analysts' Actions -- Abercrombie, Fitbit, Lowe's and More

Analysts' Actions -- Abercrombie, Fitbit, Lowe's and More

Here are Tuesday's top research calls, including new coverage of Fitbit and an upgrade of Lowe's.

Insider Trading Alert - UG, BCRX And EA Traded By Insiders

Insider Trading Alert - UG, BCRX And EA Traded By Insiders

Stocks with insider trader activity include UG, BCRX and EA

Biocryst Pharmaceuticals (BCRX) Is Today's Strong On High Volume Stock

Biocryst Pharmaceuticals (BCRX) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a strong on high relative volume candidate

Insider Trading Alert - GPK, HPQ And BCRX Traded By Insiders

Insider Trading Alert - GPK, HPQ And BCRX Traded By Insiders

Stocks with insider trader activity include GPK, HPQ and BCRX

Insider Trading Alert - BDN, MRCY And BCRX Traded By Insiders

Insider Trading Alert - BDN, MRCY And BCRX Traded By Insiders

Stocks with insider trader activity include BDN, MRCY and BCRX

Bullish Two Hundred Day Moving Average Cross - BCRX

Bullish Two Hundred Day Moving Average Cross - BCRX

In trading on Monday, shares of BioCryst Pharmaceuticals, Inc. crossed above their 200 day moving average of $10.97, changing hands as high as $11.17 per share.

Perilous Reversal Stock: Biocryst Pharmaceuticals (BCRX)

Perilous Reversal Stock: Biocryst Pharmaceuticals (BCRX)

Trade-Ideas LLC identified Biocryst Pharmaceuticals (BCRX) as a "perilous reversal" (up big yesterday but down big today) candidate

Dyax jumps after HAE data, while analysts defend competitors Shire, BioCryst

Dyax jumps after HAE data, while analysts defend competitors Shire, BioCryst

The shares of drug maker Dyax are surging after the company last night reported data from a Phase 1b clinical trial of its DX-2930 drug, a treatment for hereditary angioedema...

TheStreet Quant Rating: D- (Sell)